Biotechnology Will Dominate The 21st Century
...ironment and Forests, Shri Namo Narayan Meena said biotechnology would dominate the 21st century just as information technology dominated the last century. Addressing the 10th meeting of the Consultative Committee of the Ministry of Environment and Forests, last night, he informed the meeting that the stay on G...DBT And IAVI Forge Partnership To Develop Next Generation Vaccine Candidates
...ecretary, DBT. He said only through these kinds of biotechnology ventures involving international collaborations an...the development of the field of modern biology and biotechnology in India. Significant achievements include the growth and application of biotechnology in the broad ...Avicena to Advance Huntington's Disease Clinical Program into Phase III
...oup, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today the selection of the optimal dose of HD-02, its novel drug candidate for the treatment of Huntington's Disease. This dose was determined in a...British Scientists Develop Artificial Skin
...al skin developed by scientists at Cambridge-based biotechnology firm Intercytex could be on the market in as little as three years, with surgeons simply reaching into the fridge to retrieve pre-prepared skin as needed....Weizmann Researchers Developed Control Switch for Protein Activity
...respond to the drug. With their greater resources, biotechnology companies will be able to create much larger sets of engineered proteins in order to find one that best meets their needs. The method developed by the Weizmann Institute scientists is ready for immediate use, both in basic biomedical research and i...MS Drug Fails The Test For Treating Crohns Disease
...ve, James Mullen is not a happy man. The Cambridge biotechnology company is not likely to receive approval from European regulators to use its drug Tysabri to treat patients with Crohn's disease, a debilitating intestinal ailment. Results from drug trials that were included in an application to the European Me...Kerala Institute to Hold International Seminar on Drug Discovery
... simulation software for use in pharmaceutical and biotechnology research. The company's products range from general molecular modelling programmes to a full-featured suite of drug design software including both ligand and structure based methods.......ne could be tested in humans in the near future. A biotechnology company has already developed a monoclonal antibody specific to IL-6 which could be used to neutralize IL-6. A phase II trial is underway testing a monoclonal antibody against IL-6 for patients with multiple myeloma, a cancer that depends on IL-6 b...